Navigation Links
Halozyme to Host Third Quarter Financial Results Conference Call
Date:11/1/2012

SAN DIEGO, Nov. 1, 2012 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) will webcast its Quarterly Update Conference Call for the third quarter 2012 on Thursday, November 8, 2012 at 4:30 p.m. ET/1:30 p.m. PT. Gregory I. Frost, President and Chief Executive Officer, will lead the call. On the same date post-market, Halozyme will release financial results for the third quarter 2012.

(Logo: http://photos.prnewswire.com/prnh/20100302/LA63139LOGO)

The call will be webcast live through the "Investors" section of Halozyme's corporate website and a recording will be made available following the close of the call. To access the webcast, please log on to www.halozyme.com approximately fifteen minutes prior to the call to register, download and install any necessary audio software. For those without access to the Internet, the live call may be accessed by phone by calling (877) 407-8037 (domestic callers) or (201) 689-8037 (international callers). A telephone replay will be available shortly after the call by dialing (877) 660-6853 (domestic callers) or (201) 612-7415 (international callers) using replay ID number 402796.

About Halozyme

Halozyme Therapeutics is a biopharmaceutical company dedicated to developing and commercializing innovative products that advance patient care. With a diversified portfolio of enzymes that target the extracellular matrix, the Company's research focuses primarily on a family of human enzymes, known as hyaluronidases, that increase the absorption and dispersion of biologics. Halozyme's pipeline addresses therapeutic areas, such as diabetes, oncology and dermatology that have significant unmet medical need. The Company markets HYLENEX® recombinant (hyaluronidase human injection) and has partnerships with Roche, Baxter, ViroPharma and Intrexon. Halozyme is headquartered in San Diego, CA. For more information on how we are innovating, please visit our corporate website at www.halozyme.com.

Media/Investor Contact:
Anne Erickson  
Executive Director  
Halozyme Therapeutics  
858-704-8264  
aerickson@halozyme.com


'/>"/>
SOURCE Halozyme Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Halozyme Reports Second Quarter 2012 Financial Results
2. Halozyme Confirms Baxter Has Received A Complete Response Letter For HyQ BLA
3. Halozymes Ultrafast Insulin Formulations Improved Postprandial Glycemic Control in Patients Living with Type 1 Diabetes: Phase 2 Study Results Presented at ADA 2012
4. Halozyme Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
5. Halozyme Reports First Quarter 2012 Financial Results
6. Halozyme to Host First Quarter 2012 Financial Results Conference Call
7. BioSpecifics Technologies Corp. to Host Conference Call to Report Third Quarter 2012 Financial Results on November 8, 2012
8. PDL BioPharma to Announce Third Quarter 2012 Financial Results on November 5, 2012
9. Cumberland Pharmaceuticals Reports Third Quarter 2012 Financial Results
10. HeartWare Schedules Third Quarter Conference Call And Webcast
11. AcelRx Pharmaceuticals to Hold Third Quarter 2012 Financial Results Conference Call and Webcast on November 6, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... 23, 2016 According to ... Market by Product (Wheelchair, Scooters, Medical Beds, Bathroom ... Critical Care, Wound), Accessories (Lifting, Transfer) & by ... published by MarketsandMarkets, the patient handling equipment market ... 2021 at a CAGR of 10.5% during the ...
(Date:5/23/2016)... NEW YORK , May 23, 2016 /PRNewswire/ ... Mass Spectrometry Market Size, Share, Development, Growth and ... Platform (Hybrid, Single and Other), by Application (Drug ... Others), by End Users (Pharmaceuticals, Life Science and ... Published by P&S Market Research, the global ...
(Date:5/23/2016)... , UAE, May 23, 2016 ... importance of Precision Medicine and the role of ...   The First International Conference of VPS-Penn ... the distinguished patronage and presence of Sheikh Nahyan bin Mubarak ... focused in Precision Medicine, which helps provide personalized medicine and ...
Breaking Medicine Technology:
(Date:5/25/2016)... ... May 25, 2016 , ... Conrad Siegel ... Medical and Prescription Drug survey , an employee benefits survey ... was conducted in December 2015, indicates that employers are turning to consumer directed ...
(Date:5/25/2016)... Francisco, CA (PRWEB) , ... May 25, 2016 , ... For more than fifty years, ... en masse, we changed our diets to conform to the latest nutritional advice – advice ... According to the NIH, more than 2 in 3 American adults are considered to be ...
(Date:5/25/2016)... ... May 25, 2016 , ... BeniComp Insurance Company, ... spike in their clients' employee participation for their wellness initiatives. BeniComp clients ... a high-deductible health plan with outcome-based deductible incentives. As a result, BeniComp clients ...
(Date:5/25/2016)... ... May 25, 2016 , ... First Choice Emergency Room ... Dr. Anh Tat Nguyen, as the Medical Director of its new DeSoto facility. ... of our new DeSoto location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:5/25/2016)... ... May 25, 2016 , ... ... popular demand for minimally invasive, endoscopic spine surgeries in the Montgomery County, Howard ... seeing patients in the Germantown office of American Spine every Monday. He will ...
Breaking Medicine News(10 mins):